Flowers Foods reported second-quarter results for the 12 weeks ended July 18, 2026, with net sales down 4.0% to $1.193 billion and net income down 30.3% to $40.7 million, or $0.19 per diluted share. The company lowered its full-year 2026 outlook for net sales, adjusted EBITDA and adjusted diluted EPS, citing a more cautious view for the rest of the year. Shareholders face lower expected earnings for 2026 than previously guided.
Net sales fell 4.0% to $1.193 billion, with volume down 5.8% and pricing/mix up 1.8%.
Adjusted EBITDA fell 19.2% to $111.3 million, and adjusted diluted EPS fell $0.09 to $0.21.
Full-year 2026 adjusted diluted EPS guidance was cut to $0.75 to $0.85 from $0.80 to $0.90; net sales guidance was cut to $5.070 billion to $5.142 billion from $5.163 billion to $5.267 billion.
Management will host a live question-and-answer webcast at 8:30 a.m. Eastern Time on August 21, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Flowers Foods's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2026
$5.26B
+3.0%
$0.40
-65.8%
1.6%
FY2024
$5.10B
+0.2%
$1.17
+101.7%
4.9%
FY2023
$5.09B
+5.9%
$0.58
-45.8%
2.4%
FY2022
$4.81B
+11.0%
$1.07
+10.3%
4.8%
FY2022
$4.33B
-1.3%
$0.97
+34.7%
4.8%
Frequently asked questions
When is Flowers Foods's next earnings date?
Flowers Foods (FLO) is scheduled to report on Thursday, November 12, 2026 after the market closes. Analysts expect EPS of $0.15.
What did Flowers Foods earn last quarter?
For the quarter ended Jul 2026, Flowers Foods reported diluted EPS of $0.19 (-32.1% year over year) on revenue of $1.19B (-4.0%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.